IBio
  • Home
  • Contact Us

LinkedIn

  • Investor Relations
    Investor Relations
  • Investor Relations
    Investor Relations
Investor Relations

Investor Relations

  • Overview
  • Company Information
  • Stock Data
  • SEC Filings
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Corporate Governance
  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

Press Releases

iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment

Jan 14, 2016

iBio Continues Global Expansion of Intellectual Property

Nov 30, 2015

Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting

Nov 19, 2015

iBio European Protein Expression Patent Emerges From Opposition Period

Oct 27, 2015

New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio

Sep 30, 2015

iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides

Sep 21, 2015

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

Sep 9, 2015

iBio to Receive US Patent for Influenza Therapeutic

Aug 11, 2015

Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland

Jun 8, 2015

Vaccine Improvement Patent Awarded to iBio

May 4, 2015
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    Copyright © iBio® 2019

    (979) 446-0027,  info@ibioinc.com